Patent details
EP2993180 Title: NOVEL JNK INHIBITOR MOLECULES
Basic Information
- Publication number:
- EP2993180
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP150022119
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- NOVEL JNK INHIBITOR MOLECULES
- French Title of Invention:
- NOUVELLES MOLÉCULES D'INHIBITEUR JNK
- German Title of Invention:
- NEUARTIGE JNK-HEMMERMOLEKÜLE
- SPC Number:
Dates
- Filing date:
- 21/06/2011
- Grant date:
- 15/01/2020
- EP Publication Date:
- 09/03/2016
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 15/01/2020
- EP B1 Publication Date:
- 15/01/2020
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 21/06/2020
- Expiration date:
- 21/06/2031
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 08/01/2020
- Name:
- Xigen Inflammation Ltd.
- Address:
- Arch. Makariou III 195 Neocleous House, 3030 Limassol, Cyprus (CY)
Inventor
- Name:
- Bonny, Christophe
- Address:
- Switzerland (CH)
Priority
- Priority Number:
- PCT/EP2010/003729
- Priority Date:
- 21/06/2010
- Priority Country:
- World Intellectual Property Office (WIPO) (WO)
Classification
- IPC classification:
- C07K 7/06; C07K 14/47; G01N 33/53;
Publication
European Patent Bulletin
- Issue number:
- 202003
- Publication date:
- 15/01/2020
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|